This inventor holds 1 USPTO granted patent. Top assignees: Pfizer Corporation, Pfizer Products Inc.. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 4,490 
1 out of 47 
Years Active: 2006
Title: The Inventive Journey of Yves A Chantigny
Introduction: Yves A Chantigny, based in Groton, CT, is an accomplished inventor with significant contributions to the field of pharmacology. His work primarily focuses on the development of compounds that can modulate the glucocorticoid receptor, which plays a crucial role in treating various inflammatory conditions. With one patent to his name, Chantigny has demonstrated his innovative spirit and dedication to enhancing therapeutic options.
Latest Patents: Chantigny holds a patent titled "Modulators of the Glucocorticoid Receptor." This invention provides a specialized formula for compounds where specific variables, such as A, X, Y, n, and R, are defined in the specification. These compounds act as modulators of the glucocorticoid receptor, making them valuable for animals requiring glucocorticoid receptor agonist therapy. The implications of this patent suggest significant potential in managing inflammatory conditions effectively.
Career Highlights: Throughout his career, Yves A Chantigny has made remarkable strides in the pharmaceutical industry. He has worked with major companies, including Pfizer Corporation and Pfizer Products Inc., where he honed his skills in research and development. His expertise has allowed him to explore new therapeutic avenues and contribute to advancements in medical treatments.
Collaborations: During his professional journey, Chantigny has collaborated with notable coworkers such as Edward F Kleinman and Ralph P Robinson. These partnerships have facilitated innovative discussions and developments, ultimately leading to impactful inventions in the realm of glucocorticoid receptor modulation.
Conclusion: Yves A Chantigny stands as a noteworthy inventor whose work in modulating the glucocorticoid receptor showcases his dedication to improving medical therapies. With his patent and collaborations, he has undoubtedly left a mark on the pharmaceutical landscape, promising better treatment options for inflammatory conditions in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile